These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26873488)

  • 1. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
    Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
    Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
    Zhao Y; Miao G; Li Y; Isaji T; Gu J; Li J; Qi R
    PLoS One; 2014; 9(2):e87938. PubMed ID: 24498407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.
    Li Q; Cheng Q; Chen Z; Peng R; Chen R; Ma Z; Wan X; Liu J; Meng M; Peng Z; Jiang B
    Oncol Rep; 2016 Feb; 35(2):1125-34. PubMed ID: 26717894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
    Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT
    Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TUC.338 promotes invasion and metastasis in colorectal cancer.
    Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
    Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
    Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
    J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B; Liu X; Chang H
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
    Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.
    Chu YM; Peng HX; Xu Y; Yang DM; Zhou FL; Li J; Kuai R; Lin Y
    J Dig Dis; 2017 Mar; 18(3):169-178. PubMed ID: 28296190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
    Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
    Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
    Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
    Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network.
    Shen A; Lin W; Chen Y; Liu L; Chen H; Zhuang Q; Lin J; Sferra TJ; Peng J
    Int J Oncol; 2015 Feb; 46(2):685-90. PubMed ID: 25422078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis.
    Zhang D; Qiu X; Li J; Zheng S; Li L; Zhao H
    Cell Cycle; 2018; 17(24):2766-2778. PubMed ID: 30523755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
    Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
    Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.